METABOLIC HEALTHY OBESITY, WHAT DO WE KNOW ABOUT IT?
https://doi.org/10.21886/2219-8075-2017-8-3-6-16
Abstract
The prevalence of obesity is growing all over the world. Obesity is an important risk factor for cardiovascular diseases, type 2 diabetes. However, not all obese patients have an unfavorable cardio-metabolic profile. Recently, much attention has been paid to the concept of «metabolically healthy obesity» (MHO). To date, there are no single criteria for identifying individuals with MHO, which makes it difficult to study this subgroup of patients and to conduct a comparative analysis of various studies. The article presents data of modern literature, including the definition, prevalence and mechanisms of MHO development, also discusses potentially protective factors involved in MHO development and the consequences of the therapeutic impact on MHO.
About the Authors
N. I. Volkova
Rostov State Medical University
Russian Federation
Russian Federation
Natalya I. Volkova – M.D., Ph.D., professor of medicine, vice rector for scientific work, chief of the department of Internal Diseases III
Rostov-on-Don
L. A. Ganenko
Rostov State Medical University
Russian Federation
Russian Federation
Lilya A. Ganenko – M.D., endocrinologist, Therapeutic Department 2
Rostov-on-Don
M. I. Porksheyan
Rostov State Medical University
Russian Federation
Russian Federation
Mariya I. Porksheyan – M.D., Ph.D., Associate professor, department of Internal Diseases III
Rostov-on-Don
References
1. Non-Communicable Disease Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. La ncet.2016;387(10026):1377–1396. doi: 10.1016/S0140-6736(16)30054-X
2. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008;32:1431-1437. doi: 10.1038/ijo.2008.102
3. Keane E, Kearney PM, Perry IJ, Kelleher CC, Harrington JM. Trends and prevalence of overweight and obesity in primary school aged children in the Republic of Ireland from 2002–2012: a systematic review. BMC Public Health. 2014;14:974. doi: 10.1186/1471-2458-14-974
4. Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond). 2011;35(7):971-81. doi: 10.1038/ijo.2010.216
5. Jung CH, Lee WJ, Song KH. Metabolically healthy obesity: a friend or foe? Korean J Intern Med. 2017;32(4):611-621. doi: 10.3904/kjim.2016.259
6. Karelis A. Metabolically healthy but obese individuals. Lancet. 2008;372(9646):1281–1283. doi: 10.1016/S01406736(08)61531-7.
7. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardio-metabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168 (15):1617-1624. doi:10.1001/ar
8. Roberson L, Aneni E, Maziak W, Agatston A, Feldman T; RouseffM, et al. Beyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality-A systematic review. BMC Public Health 2014;14:1–12.
9. Van Vliet-Ostaptchouk J, Nuotio M, Slagter S, Doiron D, Fischer K, Foco L, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: A collaborative analysis of ten large cohort studies. BMC Endocr. Disord. 2014;14:9–22. doi: 10.1186/1472-6823-14-9
10. Phillips CM. Metabolically healthy obesity across the life course: epidemiology, determinants, and implications. Ann N Y Acad Sci. 2017;1391(1):85-100. doi: 1111/nyas.13230.
11. Karelis A, Rabasa-Lhoret R. Obesity: Can inflammatory status define metabolic health? Nat. Rev. Endocrinol. 2013;9(12):694–695. doi: 10.1038/nrendo.2013.198
12. Stefan N, Kantartzis K, Machann J, Schick F, Th amer C, Rittig K, et al. Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 2008;168(15):1609–1616. doi: 10.1001/archinte.168.15.1609
13. Phillips CM, Dillon C, Harrington JM, McCarthy VJ, Kearney PM, Fitzgerald AP, et al . Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS One. 2013;8(10):e76188. doi:10.1371/journal.pone.0076188
14. Yoo HK, Choi EY, Park EW, Cheong YS, Bae RA. Comparison of metabolic characteristics of metabolically healthy but obese (MHO) middle-aged men according to different criteria. Korean J. Fam. Med. 2013;34(1):19-26. doi: 10.4082/kjfm.2013.34.1.19
15. Velho S, Paccaud F, Waeber G, Vollenweider P, MarquesVidal P. Metabolically healthy obesity: different prevalences using different criteria. Eur. J. Clin. Nutr. 2010;64(10):1043– 1051. doi: 10.1038/ejcn.2010.114
16. Phillips CM. Metabolically healthy obesity across the life course: epidemiology, determinants, and implications. Ann N Y Acad Sci. 2017;139(1):85-100. doi: 10.1111/nyas.13230
17. Arsenault BJ, Lachance D, Lemieux I, Alméras N, Tremblay A, Bouchard C et al. Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome. Arch Intern Med. 2007;167(14):1518-1520. doi: 10.1001/archinte.167.14.1518
18. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881-887. doi: 10.1038/nature05488
19. Kunnas T, Lahtio R, Kortelainen ML, Kalela A, Nikkari ST. Gln27Glu variant of Beta2-adrenoceptor gene affects male type fat accumulation in women. Lipids Health Dis. 2009;8:43. doi: 10.1186/1476-511X-8-43
20. Ferguson JF, Phillips CM, Tierney AC, Pérez-Martínez P, Defoort C, Helal O, et al. Gene–nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. Am. J. Clin. Nutr. 2010 ;91(3) :794–801. doi: 10.3945/ajcn.2009.28255
21. Phillips CM, Goumidi L, Bertrais S, Field MR, Ordovas JM, Cupples LA, et al. Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults. J. Nutr. 2010;140(2):238–244. doi: 10.3945/jn.109.115329
22. Kvaloy K, Holmen J, Hveem K, Holmen TL. Genetic effects on longitudinal changes from healthy to adverse weight and metabolic status—the HUNT study. PLoS One. 2015;10(10):e0139632. doi: 10.1371/journal.pone.0139632
23. Sutherland J, McKinley B, Eckel R. The metabolic syndrome and inflammation. Metab. Syndr. Relat. Disord. 2004;2(2):82– 104. doi: 10.1089/met.2004.2.82
24. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud’homme D, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab. 2005;90(7):4145–4150. doi: 10.1210/jc.2005-0482
25. Gomez-Ambrosi J, Catalan V, Rodriguez A, Andrada P, Ramírez B, Ibáñez P, et al. Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. Diabetes Care. 2014;37(10):2813–2821. doi: 10.2337/dc14-0937
26. Ahl S, Guenther M, Zhao S, James R, Marks J, Szabo A, et al. Adiponectin Levels Differentiate Metabolically Healthy vs Unhealthy Among Obese and Nonobese White Individuals. J Clin Endocrinol Metab. 2015;100(11):4172–4180. doi: 10.1210/jc.2015-2765
27. Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, Church TS, et al. The intriguing metabolically healthy but obese phenotype: Cardiovascular prognosis and role of fitness. Eur. Heart J. 2013;34(5):389–397. doi: 10.1093/eurheartj/ehs174
28. Jennings CL, Lambert EV, Collins M, Joffe Y, Levitt NS, Goedecke JH. Determinants of insulin-resistant phenotypes in normal-weight and obese Black African women. Obesity (Silver Spring). 2008;16(7):P.1602-9. doi: 10.1038/oby.2008.233
29. Camhi SM, Whitney Evans E, Hayman LL, Lichtenstein AH, Must A. Healthy eating index and metabolically healthy obesity in U.S. adolescents and adults. Prev. Med. 2015;77:23–27. doi: 10.1016/j.ypmed.2015.04.023
30. Pujia A, Gazzaruso C, Ferro Y, Mazza E, Maurotti S, Russo C, et al. Individuals with Metabolically Нealthy Overweight/ Obesity Have Higher Fat Utilization than Metabolically Unhealthy Individuals. Nutrients. 2016;8(1):2. doi:10.3390/nu8010002
31. Park YM, Steck SE, Fung TT, Zhang J, Hazlett LJ, Han K, et al. Mediterranean diet and mortality risk in metabolically healthy obese and metabolically unhealthy obese phenotypes. Int. J. Obes. 2016;40(10):1541-1549. doi: 10.1038/ ijo.2016.114
32. Phillips CM, Perry IJ. Does inflammation determine metabolic health status in obese and nonobese adults? J Clin Endocrinol Metab. 2013;98(10):E1610–E1619. doi: 10.1210/ jc.2013-2038
33. Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nature Reviews. Gastroenterology and Hepatology. 2012;9(10):577–589. doi:10.1038/nrgastro.2012.156
34. Aung K, Lorenzo C, Hinojosa MA, Haffner SM. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab. 2014;99(2):462–468. doi: 10.1210/jc.2013-2832
35. Hinnouho GM, Czernichow S, Dugravot A, Nabi H, Brunner EJ, Kivimaki M, et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J. 2015;36(9):551– 559. doi: 10.1093/eurheartj/ehu123
36. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J. Clin. Endocrinol. Metab. 2012;97(7):2482–2488. doi: 10.1210/jc.2011-3475
37. Flint AJ, Hu FB, Glynn RJ, Caspard H, Manson JE, Willett WC, et al. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring). 2010;18(2):377–383. doi: 10.1038/oby.2009.223
38. Kang YM, Jung CH, Jang JE, Hwang JY, Kim EH, Park JY, et al. The association of incident hypertension with metabolic health and obesity status: definition of metabolic health does not matter. Clin Endocrinol (Oxf). 2016;85(2):207–215. doi: 10.1111/cen.13074
39. Arnlov J, Sundstrom J, Ingelsson E, Lind L. Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men. Diabetes Care. 2011;34(1):61–65. doi: 10.2337/ dc10-0955
40. Lassale C, Tzoulaki I, MoonsK.GM, Sweeting M, Boer J, Johnson L, et al. Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis. European Heart Journal. 2017:ehx448. doi: 10.1093/eurheartj/ehx448
41. Zheng R, Zhou D, Zhu Y. The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and meta-analysis. J Epidemiol Community Health. 2016;70(10):1024-31. doi: 10.1136/jech-2015-206948
42. Hashimoto Y, Tanaka M, Okada H, Senmaru T, Hamaguchi M, Asano M, et al. Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol. 2015 ;10(4) :578–583. doi: 10.2215/CJN.08980914
43. Chang Y, Ryu S, Choi Y, Zhang Y, Cho J, Kwon MJ, et al. Metabolically healthy obesity and development of chronic kidney disease: a cohort study. Ann Intern Med. 2016;164(5):305– 312. doi: 10.7326/M15-1323
44. Janiszewski PM, Ross R. Effects of weight loss among metabolically healthy obese men and women. Diabetes Care. 2010;33(9):1957–1959. doi: 10.2337/dc10-0547
45. Kantartzis K, Machann J, Schick F, Rittig K, Machicao F, Fritsche A, et al. Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia. 2011;54(5):864– 868. doi: 10.1007/s00125-010-2006-3
46. Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y, Lee JH. Weight loss effect on inflammation and LDL oxidation in metaboli cally healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (London). 2006;30(10):1529–1534. DOI: 10.1038/sj.ijo.0803304
47. Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R. Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia. 2008;51(9):1752-4. doi: 10.1007/s00125008-1038-4
48. Liu RH, Wharton S, Sharma AM, Ardern CI, Kuk JL. Influence of a clinical lifestyle-based weight loss program on the metabolic risk profile of metabolically normal and abnormal obese adults. Obesity (Silver Spring). 2013;21(8):1533–1539. doi: 10.1002/oby.20219
49. Dalleck LC, Van Guilder GP, Richardson TB, Bredle DL, Janot JM. A community-based exercise intervention transitions metabolically abnormal obese adults to a metabolically healthy obese phenotype. Diabetes Metab. Syndr. Obes. 2014;7:369–380. doi: 10.2147/DMSO.S67441
50. Soriguer F, Gutiérrez-Repiso C, Rubio-Martín E, GarcíaFuentes E, Almaraz MC, Colomo N, et al. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrinol Metab. 2013;98(6):2318–2325. doi: 10.1210/jc.2012-4253
51. Li S, Chen W, Srinivasan SR, Xu J, Berenson GS. Relation of childhood obesity/cardiometabolic phenotypes to adult cardiometabolic profile: the Bogalusa Heart Study. Am. J. Epidemiol. 2012;176(7):S142–S149. doi: 10.1093/aje/kws236
52. Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013;36(8):2388–2394. doi: 10.2337/dc121971
53. Eshtiaghi R, Keihani S, Hosseinpanah F, Barzin M, Azizi F. Natural course of metabolically healthy abdominal obese adults aft er 10 years of follow-up: the Tehran Lipid and Glucose Study. Int. J. Obes. 2015;39(3):514–519. doi: 10.1038/ ijo.2014.176
54. Hamer M, Bell JA, Sabia S, Batty GD, Kivimäki M. Stability of metabolically healthy obesity over 8 years: the English Longitudinal Study of Ageing. Eur. J. Endocrinol. 2015;173(5):703–708. doi: 10.1530/EJE-15-0449
55. Schröder H, Ramos R, Baena-Díez JM, Mendez MA, Canal DJ, Fíto M, et al. Determinants of the transition from a cardiometabolic normal to abnormal overweight/ obese phenotype in a Spanish population. Eur J Nutr. 2014;53(6):1345–1353. doi: 10.1007/s00394-013-0635-2
56. Bluher M. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol. 2010;21(1):38– 43. doi: 10.1097/MOL.0b013e3283346ccc
57. Volkova NI, Porksheyan MI, Gyulmagomedova AN. Treatment for obesity: the history of flights&falls. Medical Herald of the South of Russia. 2015;(1):21-26. (In Russ.) DOI:10.21886/2219-8075-2015-1-21-26
58. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda (MD): National Heart, Lung, and Blood Institute; 1998.
Review
For citations:
Volkova N.I., Ganenko L.A., Porksheyan M.I. METABOLIC HEALTHY OBESITY, WHAT DO WE KNOW ABOUT IT? Medical Herald of the South of Russia. 2017;8(3):6-16. (In Russ.) https://doi.org/10.21886/2219-8075-2017-8-3-6-16
Views:
980
Email this article 